 | |
< HOME < IR OVERVIEW |
|
|
| INVESTOR RELATIONS OVERVIEW
 | Webcast Icagen Inc at JPMorgan Healthcare Conference (Replay) 01/14/10 at 11:30 a.m. PT |
Stock Quote
ICGN (Common Stock) | Icagen is a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads.
Ion channels are protein structures found in virtually every cell of the human body. Ion channels span the cell membrane and regulate the flow of ions, which are charged particles such as sodium, potassium, calcium and chloride, into and out of cells. There are currently 35 drugs that modulate ion channels and are marketed by third par... + more| There are currently no events scheduled. |
| Receive E-mail Alerts | | Sign up to receive e-mail alerts whenever Icagen, Inc. posts new information to the site. Just enter your e-mail address and click Submit. |
 |  |  | | Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |
|
|
|
| |